G
LABU icon

Gainplan’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Gainplan’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,000
Closed -$664K – 72
2024
Q1 		$664K Buy
+5,000
New +$653K 0.32% 29
2023
Q3 		– Sell
-3,750
Closed -$444K – 49
2023
Q2 		$444K Buy
+3,750
New +$467K 0.24% 27
2020
Q3 		– Sell
-750
Closed -$891K – 44
2020
Q2 		$891K Buy
+750
New +$650K 0.58% 14
2019
Q4 		– Sell
-750
Closed -$464K – 59
2019
Q3 		$464K Buy
750
+250
+50% +$208K 0.28% 22
2019
Q2 		$502K Buy
+500
New +$484K 0.3% 19
2019
Q1 		– Sell
-500
Closed -$329K – 30
2018
Q4 		$329K Buy
+500
New +$524K 0.32% 11

Other funds holding LABU

TAA
TB Alternative Assets Grand Cayman, Cayman Islands $481M AUM 61.7% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return